Farrell Michael J.
Farrell Michael J., CHAIR, reported a transaction classified as exercise at RESMED INC involving 4991.000000 shares for an estimated $0.00. Reported holdings after the transaction were 9984.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RMD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0000943819-26-000052 ResMed Common Stock Options
- Transaction date
- Sep 08, 2026 Filed Sep 10, 2026, 10:40 AM · 2d delay
- Shares
- 4,991 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 9,984 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chairman and CEO
- F1
The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.
- F2
This transaction was executed in multiple trades at prices ranging from $220.680 - $225.390. The price reported above reflects the weighted average sale price.
- F3
Represents date options first become exercisable. Options vest 1/3 per year.
0 other transactions
0 recent txs